These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8748136)

  • 21. Human insulin-like growth factor binding protein-1 (hIGFBP-1) transgenic mice: insights into hIGFBP-1 regulation and actions.
    D'Ercole AJ; Ye P; Dai Z
    Prog Growth Factor Res; 1995; 6(2-4):417-23. PubMed ID: 8817685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3.
    Lewitt MS; Saunders H; Baxter RC
    Endocrinology; 1993 Oct; 133(4):1797-802. PubMed ID: 7691582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3.
    Conover CA
    Endocrinology; 1991 Dec; 129(6):3259-68. PubMed ID: 1720092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency.
    Liao L; Dearth RK; Zhou S; Britton OL; Lee AV; Xu J
    Endocrinology; 2006 Aug; 147(8):3877-88. PubMed ID: 16709615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction.
    Watson CS; Bialek P; Anzo M; Khosravi J; Yee SP; Han VK
    Endocrinology; 2006 Mar; 147(3):1175-86. PubMed ID: 16293667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.
    Silha JV; Mishra S; Rosen CJ; Beamer WG; Turner RT; Powell DR; Murphy LJ
    J Bone Miner Res; 2003 Oct; 18(10):1834-41. PubMed ID: 14584894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion.
    Nguyen KH; Yao XH; Moulik S; Mishra S; Nyomba BL
    Endocrinology; 2011 Jun; 152(6):2184-96. PubMed ID: 21447640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth.
    Wolf E; Kramer R; Blum WF; Föll J; Brem G
    Endocrinology; 1994 Nov; 135(5):1877-86. PubMed ID: 7525257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of mouse follistatin causes reproductive defects in transgenic mice.
    Guo Q; Kumar TR; Woodruff T; Hadsell LA; DeMayo FJ; Matzuk MM
    Mol Endocrinol; 1998 Jan; 12(1):96-106. PubMed ID: 9440814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasia.
    Lu S; Archer MC
    Mol Carcinog; 2003 Mar; 36(3):142-6. PubMed ID: 12619036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
    Lassarre C; Binoux M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats.
    Lewitt MS; Saunders H; Phuyal JL; Baxter RC
    Endocrinology; 1994 Jun; 134(6):2404-9. PubMed ID: 7514998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
    Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice.
    Smink JJ; Koster JG; Hendriks-Stegeman BI; Van Buul-Offers SC
    Endocrinology; 1999 Dec; 140(12):5876-82. PubMed ID: 10579353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different molecular and messenger ribonucleic acid forms of insulin-like growth factor-binding protein-3 in the pregnant baboon (Papio anubis).
    Gargosky SE; Giudice LC; Rosenfeld RG; Fazleabas AT
    J Endocrinol; 1995 Dec; 147(3):449-61. PubMed ID: 8543915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I.
    Camacho-Hubner C; Clemmons DR; D'Ercole AJ
    Endocrinology; 1991 Sep; 129(3):1201-6. PubMed ID: 1714829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
    Hoeflich A; Nedbal S; Blum WF; Erhard M; Lahm H; Brem G; Kolb HJ; Wanke R; Wolf E
    Endocrinology; 2001 May; 142(5):1889-98. PubMed ID: 11316754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice.
    Zhou R; Flaswinkel H; Schneider MR; Lahm H; Hoeflich A; Wanke R; Wolf E
    J Mol Endocrinol; 2004 Apr; 32(2):349-64. PubMed ID: 15072544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum.
    Liu F; Baxter RC; Hintz RL
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1261-7. PubMed ID: 1385469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of urinary insulin-like growth factor binding proteins.
    Hasegawa Y; Cohen P; Yorgin P; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):830-5. PubMed ID: 1372323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.